Literature DB >> 24203464

Epidermal growth factor promotes transforming growth factor-β1-induced epithelial-mesenchymal transition in HK-2 cells through a synergistic effect on Snail.

Jun Xiong1, Qing Sun, Kaihong Ji, Yue Wang, Houqi Liu.   

Abstract

Epithelial-mesenchymal transition (EMT) is a central mechanism for wound healing, tissue repair, organ fibrosis and carcinoma progression in adults. Evidence shows that both epidermal growth factor (EGF) and transforming growth factor-β1 (TGF-β1) are upregulated during renal interstitial fibrosis, and that co-stimulation of EGF and TGF-β1 could induce renal tubular epithelial cells to undergo EMT more effectively than EGF or TGF-β1 alone. This study was intended to explore the molecular mechanism underlying this effect. HK-2 cells underwent apparent EMT with increased cell motility after co-stimulation of EGF and TGF-β1 as compared with TGF-β1 or EGF alone. Co-stimulation of EGF and TGF-β1 resulted in rapid and robust ERK1/2 activation and induced persistent high expression of Snail protein. Treatment with the MEK inhibitor U0126 followed by co-stimulation with EGF and TGF-β1 prevented the upregulation of Snail protein, EMT and motility, without impairing Snail mRNA. TGF-β1 induced Snail at the transcriptional level, which was not influenced by EGF. Inhibition of Snail expression by siRNA interference also prevented EMT caused by co-stimulation of EGF and TGF-β1. These data suggest that EGF promotes TGF-β1-induced EMT through a synergistic effect on Snail at the post-transcriptional level in HK-2 cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24203464     DOI: 10.1007/s11033-013-2857-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  39 in total

1.  TGF-β induces sustained upregulation of SNAI1 and SNAI2 through Smad and non-Smad pathways in a human corneal epithelial cell line.

Authors:  Keiichi Aomatsu; Tokuzo Arao; Koji Sugioka; Kazuko Matsumoto; Daisuke Tamura; Kanae Kudo; Hiroyasu Kaneda; Kaoru Tanaka; Yoshihiko Fujita; Yoshikazu Shimomura; Kazuto Nishio
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-14       Impact factor: 4.799

2.  The morphological and molecular features of the epithelial-to-mesenchymal transition.

Authors:  Gema Moreno-Bueno; Héctor Peinado; Patricia Molina; David Olmeda; Eva Cubillo; Vanesa Santos; José Palacios; Francisco Portillo; Amparo Cano
Journal:  Nat Protoc       Date:  2009-10-15       Impact factor: 13.491

3.  Interaction between the transforming growth factor-beta type II receptor/Smad pathway and beta-catenin during transforming growth factor-beta1-mediated adherens junction disassembly.

Authors:  Ya Chung Tian; Aled Owain Phillips
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

4.  HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney.

Authors:  M J Ryan; G Johnson; J Kirk; S M Fuerstenberg; R A Zager; B Torok-Storb
Journal:  Kidney Int       Date:  1994-01       Impact factor: 10.612

Review 5.  Renal fibrosis: novel insights into mechanisms and therapeutic targets.

Authors:  Peter Boor; Tammo Ostendorf; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2010-09-14       Impact factor: 28.314

6.  Distinctive mechanism for sustained TGF-β signaling and growth inhibition: MEK1 activation-dependent stabilization of type II TGF-β receptors.

Authors:  Gang Chen; Paritosh Ghosh; Dan L Longo
Journal:  Mol Cancer Res       Date:  2010-12-03       Impact factor: 5.852

Review 7.  Renal fibrosis: new insights into the pathogenesis and therapeutics.

Authors:  Youhua Liu
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

8.  Epidermal growth factor and transforming growth factor-beta1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway.

Authors:  Ya-Chung Tian; Yung-Chang Chen; Chiz-Tzung Chang; Cheng-Chieh Hung; Mai-Szu Wu; Aled Phillips; Chih-Wei Yang
Journal:  Exp Cell Res       Date:  2007-03-30       Impact factor: 3.905

9.  Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion.

Authors:  Zhimin Lu; Sourav Ghosh; Zhiyong Wang; Tony Hunter
Journal:  Cancer Cell       Date:  2003-12       Impact factor: 31.743

Review 10.  TGF-beta-induced epithelial to mesenchymal transition.

Authors:  Jian Xu; Samy Lamouille; Rik Derynck
Journal:  Cell Res       Date:  2009-02       Impact factor: 25.617

View more
  6 in total

1.  Growth factor functionalized biomaterial for drug delivery and tissue regeneration.

Authors:  Alex Leonard; Piyush Koria
Journal:  J Bioact Compat Polym       Date:  2017-05-05       Impact factor: 1.756

2.  Hirsutella sinensis Attenuates Aristolochic Acid-Induced Renal Tubular Epithelial-Mesenchymal Transition by Inhibiting TGF-β1 and Snail Expression.

Authors:  Xiao-Yi Xu; Jing-Jing Chai; Yi-Pu Chen; Hong-Liang Rui; Yan-Yan Wang; Hong-Rui Dong; Yu-Lin Man; Hong Cheng
Journal:  PLoS One       Date:  2016-02-18       Impact factor: 3.240

3.  AEBP1 Is One of the Epithelial-Mesenchymal Transition Regulatory Genes in Colon Adenocarcinoma.

Authors:  Dandan Li; Zhi Liu; Xiaorong Ding; Zhensheng Qin
Journal:  Biomed Res Int       Date:  2021-12-12       Impact factor: 3.411

4.  Numb-PRRL promotes TGF-β1- and EGF-induced epithelial-to-mesenchymal transition in pancreatic cancer.

Authors:  Weiwei Sheng; Jingtong Tang; Rongxian Cao; Xiaoyang Shi; Yuteng Ma; Ming Dong
Journal:  Cell Death Dis       Date:  2022-02-23       Impact factor: 8.469

5.  Tubular Overexpression of Angiopoietin-1 Attenuates Renal Fibrosis.

Authors:  Sudhir Singh; Scott R Manson; Heedoo Lee; Yeawon Kim; Tuoen Liu; Qiusha Guo; Julio J Geminiani; Paul F Austin; Ying Maggie Chen
Journal:  PLoS One       Date:  2016-07-25       Impact factor: 3.240

6.  TGF-β transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK/Sp1 signaling pathways.

Authors:  Yuanyuan Zhao; Jing Ma; Yanling Fan; Zhiyong Wang; Ran Tian; Wei Ji; Fei Zhang; Ruifang Niu
Journal:  Mol Oncol       Date:  2018-01-24       Impact factor: 6.603

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.